Maxigesic hopes for US shot in the arm

Staff reporters
Fri, 07 Jan 2022

AFT founder Hartley Atkinson. (Image: supplied)
AFT founder Hartley Atkinson. (Image: supplied)
Staff reporters
Fri, 07 Jan 2022
NZ drug firm AFT Pharmaceuticals is readying for a US push with both the tablet and intravenous form of its successful Maxigesic pain-relief medicine awaiting approval.The company said in a letter to shareholders published on the NZX it was evaluating its plans to ensure it gets the best outcome for Maxigesic in the US, the biggest market for pain relief.Maxigesic is a combination of the common over-the-counter pain medications paracetamol and ibuprofen.AFT said the US Food and Drug Administration (FDA) is due to respond to AFT’s applicat...

Not convinced yet?

Subscribe to our Daily News Update free newsletter.

Markets Market close
NZ shares slide on recession risk
Dan Brunskill | Tue, 17 May 2022

Central banks are expected to rapidly tighten policy, the risk of an energy crisis in Europe remains, and economic activity in China has been slowing.

BitPrime calls on crypto community for cash
Dan Brunskill | Tue, 17 May 2022

The crypto retailers plan to create a decentralised autonomous organisation to give supporters a say in how the business is run. 

Tracksuit a good fit for brand tracking
Ben Moore | Tue, 17 May 2022

Startup Tracksuit is simplifying brand tracking as digital marketing faces the death of online tracking.

Grow your business by taking time to plan

Getting business fundamentals right gives the best chance at beating the unplannable.

Partner content
More fuel storage needed now

Boosting fuel reserves could prevent social & economic disruption.